Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Diabetic patients suffering diabetic foot ulcers (wounds) are benefiting from pioneering efforts in wound therapy. Tissue Regenix, an international medical technology company is leading the development of a range of regenerative products to make specialized replacement tissue using biological (human & animal) materials.
The company offers an expanding roster of products based on their patented dCELL® decellularization technology to provide acellular tissue scaffolds which are not rejected by the patient’s body. DermaPure® is a new decellularized human dermis product from Tissue Regenix used by physicians to help promote wound healing. Initial clinical use has demonstrated that DermaPure® allografts may have scaffold characteristics – including elasticity, porosity and bio-compatibility – comparable to natural tissue, which have been shown to promote beneficial cellular activity during healing.

Don’t move! The Balancing Act is back with a new Behind the Mystery segment and an inside look at a Broadway sensation.

We're discussing Alport syndrome, a rare, genetic, and chronic kidney condition characterized by declining kidney function which can lead to end-stage kidney disease.

When it comes to facial and body rejuvenation, discover a patient-first, non-surgical approach at Jupiter Plastic Surgery Center.

Comments

comments